Universe Pharmaceuticals INC (UPC) Operating margin 2019–2025
Universe Pharmaceuticals INC (UPC) operating margin by fiscal year — reported operating income divided by reported revenue.
-16.3%FY2025 · since FY2019: 29.4% → -16.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.3% | +18.5 pp |
| FY2024 | -34.8% | -22.6 pp |
| FY2023 | -12.3% | +5.2 pp |
| FY2022 | -17.5% | -45.8 pp |
| FY2021 | 28.3% | -5.1 pp |
| FY2020 | 33.4% | +4.0 pp |
| FY2019 | 29.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice